Search for: "Sanofi-Aventis US Inc"
Results 21 - 40
of 160
Sorted by Relevance
|
Sort by Date
16 Jun 2010, 2:04 am
Pharmaceuticals (Sanofi-Aventis), banks and finance (Citigroup, Inc., MasterCard International Incorporated) , fashion (Christian Dior Couture), retail (Harrods Limited, Burberry Limited), hotels and travel (Sheraton International Inc.), automobiles (Bayerische Motoren Werke AG (BMW AG)) and toy manufacturers (LEGO Juris A/S) are frequent targets. [read post]
11 May 2023, 10:12 am
By Chris Holman Sanofi-Aventis Deutschland GMBH v. [read post]
27 Aug 2019, 9:59 pm
The case arose in ANDA litigation involving Sanofi's Jevtana® (cabazitaxel), having the structure: where the methoxy... [read post]
27 Sep 2020, 6:36 pm
Arthrex, Inc., No. 19-1452; Sanofi-Aventis Deutschland GmbH v. [read post]
26 Jul 2014, 9:14 pm
Methods of medical treatment came under scrutiny of the US Supreme Court in Mayo Collaborative Services v Prometheus Laboratories, Inc and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (see High Court Rules Methods of Medical Treatment Patent-Eligible). [read post]
5 Oct 2020, 10:25 am
Arthrex, Inc., No. 19-1452; Sanofi-Aventis Deutschland GmbH v. [read post]
6 Sep 2007, 2:56 pm
Ketek can still be used to treat certain types of pneumonia.More information about these restrictions imposed on Ketek in Canada are set forth in the accompanying "PUBLIC COMMUNICATION Health Canada Endorsed Important Safety Information on KETEK (telithromycin)" and the the so-called "Dear Doctor" letter sent to health care professionals by Sanofi-aventis Canada Inc. on August 30, 2007. [read post]
21 May 2010, 2:32 am
Two recent examples of disclaimers bolstering bad faith are Sanofi-Aventis, Aventis Pharma SA, Aventis Pharmaceuticals Inc. v. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/21: Aventis Pharama S.A., Sanofi-Aventis US LLC v. [read post]
22 Jul 2011, 2:34 pm
" (8/4/11, Health Canada MedEffect e-Notice) Multaq (dronedarone), Sanofi-aventis Canada Inc., must not be prescribed to patients with permanent atrial fibrillation. [read post]
16 Dec 2020, 9:10 am
Sanofi-Aventis U.S. [read post]
2 May 2021, 1:41 pm
Sanofi-Aventis. [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]
19 Apr 2014, 8:50 am
Rev. 629 (2009) :Teva recruited a predecessor of Sanofi-Aventis to help sell its multiple sclerosis drug Copaxone. [read post]
31 Aug 2010, 10:01 pm
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
16 Dec 2009, 2:51 pm
Merck's animal health business is conducted through a joint venture equally owned by Merck and Sanofi-Aventis S.A. [read post]
19 Apr 2012, 10:00 pm
If there are any patent blogs you think should be highlighted by our Top 5, please comment on this post and we'll check them out. 1) CAFC Blog: Revisiting Therasense, CAFC Finds That An Inventor's Subjective Belief That Submission of Documents Was Unnecessary May Not be Sufficient to Avoid a Showing Of Intent to Deceive - This post discusses Aventis Pharma S.A. and Sanofi-Aventis U.S. [read post]
19 Apr 2012, 10:00 pm
If there are any patent blogs you think should be highlighted by our Top 5, please comment on this post and we'll check them out. 1) CAFC Blog: Revisiting Therasense, CAFC Finds That An Inventor's Subjective Belief That Submission of Documents Was Unnecessary May Not be Sufficient to Avoid a Showing Of Intent to Deceive - This post discusses Aventis Pharma S.A. and Sanofi-Aventis U.S. [read post]
18 Aug 2017, 2:15 pm
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
18 Aug 2017, 2:15 pm
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
